Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States

Running, not enrolling

Conditions studied: Acute Lymphoblastic Leukemia

In brief

The overall goals of this study are to measure parents' financial distress (worry or anxiety about money) during their child's/adolescent's treatment for acute lymphoblastic leukemia and whether it changes over time, and to learn what factors are associated with changes in financial distress. Information gathered from this study will inform future intervention studies that may mitigate financial distress for parents of children/adolescents being treated for acute lymphoblastic leukemia.

Key facts

Study ID

NCT04928599

Run by

Children's Oncology Group

People needed

100

Starts

2022-03-14

Expected to finish

2028-03-31

Last updated by the study team

2026-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All Children's Oncology Group (COG) NCI Community Oncology Research Program (National Cancer Institute [N]CORP) institutions are eligible for participation in this study upon first parent enrollment
• Parents of an index child who meets the following characteristics are eligible for this study:
• Index child must be newly diagnosed with de novo ALL
• Index child must be between the ages of 1 and 14.9 years at the time of the parent's enrollment
• At the parent's entry to the study, the index child must be receiving induction chemotherapy for newly diagnosed ALL at the enrolling institution. The index child may be enrolled in therapeutic clinical ALL trials or receiving ALL therapy per standard of care
• Parents age 18 years and above are eligible for this study
• Parent must speak English or Spanish in order to participate in the consent process and provide consent. The parent's language skills must be sufficient to understand the study requirements and complete the survey and interview questions
• At the parent's entry to the study, the index child must be receiving induction chemotherapy for newly diagnosed ALL at the enrolling institution. The index child may be enrolled in therapeutic clinical ALL trials or receiving ALL therapy per standard of care
• REGULATORY REQUIREMENTS: All parents must sign a written informed consent for their participation in the study
• REGULATORY REQUIREMENTS: All institutional and NCI requirements for human studies must be met

You may not qualify if…

• Parents of index children with any of the following clinical characteristics will be excluded from the study:
• KMT2A-R (formerly MLL-R) not receiving ALL therapy
• Mixed-phenotype acute leukemia (MPAL) not receiving ALL therapy
• Burkitt's leukemia

Where it is running

• Kaiser Permanente-Oakland — Oakland, California, United States
• Alfred I duPont Hospital for Children — Wilmington, Delaware, United States
• Broward Health Medical Center — Fort Lauderdale, Florida, United States
• Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida, United States
• Memorial Regional Hospital/Joe DiMaggio Children's Hospital — Hollywood, Florida, United States
• Nemours Children's Clinic-Jacksonville — Jacksonville, Florida, United States
• Nemours Children's Hospital — Orlando, Florida, United States
• Sacred Heart Hospital — Pensacola, Florida, United States
• Tampa General Hospital — Tampa, Florida, United States
• Saint Joseph's Hospital/Children's Hospital-Tampa — Tampa, Florida, United States
• Augusta University Medical Center — Augusta, Georgia, United States
• Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States
• Blank Children's Hospital — Des Moines, Iowa, United States
• Children's Hospital New Orleans — New Orleans, Louisiana, United States
• Ochsner Medical Center Jefferson — New Orleans, Louisiana, United States
• Maine Children's Cancer Program — Scarborough, Maine, United States
• Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan, United States
• Bronson Methodist Hospital — Kalamazoo, Michigan, United States
• Mercy Hospital Saint Louis — St Louis, Missouri, United States
• University Medical Center of Southern Nevada — Las Vegas, Nevada, United States
• Sunrise Hospital and Medical Center — Las Vegas, Nevada, United States
• Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada, United States
• Summerlin Hospital Medical Center — Las Vegas, Nevada, United States
• Renown Regional Medical Center — Reno, Nevada, United States
• Morristown Medical Center — Morristown, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.